FIRST AUTHOR INDEX |
Last Name |
First Name |
No. |
Title |
Leif |
Bertilsson |
SL1
|
History of pharmacogenetics in relation to clinical psychopharmacology |
R Uhl |
George |
SL-2 |
Genome wide association data and Neuropsychopharmacology |
Addington |
Donald |
CL-1 |
Recognition and Treatment of Depression in Schizophrenia |
OGO |
MAKOTO |
S4-4 |
Recent progress of disease-modifying approach to the treatment for Alzheimer's disease |
Takahashi |
Hidehiko |
S9-4 |
Prospects for the understanding impairments of social emotions in neuropsychiatric disorders |
Tomotake |
Masahito |
S11-1 |
Relation among cognitive dysfunction, quality of life and clinical symptoms in schizophrenia patients |
Sumiyoshi |
Tomiki |
S11-2 |
Neurophysiological basis for cognitive defi cits of schizophrenia and effect of psychotropic drugs |
Green |
Michael |
S11-3 |
Social cognition in schizophrenia: Why is it important and how can we improve it? |
Spina |
Edoardo |
LS1 |
Clinically relevant drug interactions with newer antidepressants |
F. Green |
Michael |
LS2 |
Drug treatments for cognitive impairment in schizophrenia |
Bertilsson |
Leif |
LS5 |
Antidepressant drugs – Pharmacogenetics and drug-drug interactions |
Addington |
Donald |
LS6 |
Recognition and Treatment of Patients at Clinical High Risk for Developing Schizophrenia |
Tanabe |
Yoichiro |
O1-B3 |
Examination of the comprehensive gene expression in the SK-S-SH cell by the LTG dosage |
Yoshimura |
Reiji |
O1-C3 |
Effi cacies of a low dose atypical antipsychotic drug addition to an antidepressant and its effects on plasma brain-derived neurotrophic factor levels in refractory depression |
Nakajima |
Shinichiro |
O1-C4 |
Benefi ts of Switching Antidepressants Following Early Nonresponse |
Takeuchi |
Hiroyoshi |
O1-D6 |
How long to wait before reducing antipsychotic dosage in stabilized patients with schizophrenia? A retrospective chart review |
Uchida |
Hiroyuki |
O2-F1 |
Predicting Antipsychotic Plasma Concentrations Before Titrating The Dose: A Population Pharmacokinetic Study |
Unemura |
Kazuhiro |
O2-I 4 |
Glucocorticoid-induced inhibition of astrocytic proliferation by the decrease of the expression of glucocorticoid receptor in cortical culture |
Furuyashiki |
Tomoyuki |
O3-L4 |
Roles of prostaglandin E2 and its receptor EP1 in adaptive selection of emotional behaviors |
H Kalali |
Amir |
O3-N4 |
Crisis in CNS Drug Development: Current Challenges and Possible Solutions |
Takano |
Katsura |
O3-P5 |
A dibenzoylmethane derivative inhibits lipopolysaccharide-induced NO production in cultured rat astrocytes |
Suzuki |
Yutaro |
P1-AVIII2 |
The wide variability of perospirone metabolism and the effect of perospirone on prolactin in psychiatric patients |
Ishitobi |
Makoto |
P1-B2 |
Adjunctive treatment with low-dosage aripiprazole for blonanserin-induced hyperprolactinemia in a female patient with schizophrenia |
Matsuoka |
Tadasu |
P1-C3 |
Change in the expressions of myelination/oligodendrocyte- related genes during puberty in the rat brain |
Kawagoe |
Hirofumi |
P1-F5 |
Promoted expression of glia-derived neurotrophic factor in cultured rat cortical astrocytesexposed to nicotine |
Kato |
Masaki |
P1-HI5 |
New functional variant in SLC6A4 gene as candidate of the individualized treatment of depression -The result of RCT- |
Kerise |
Lyttle |
P1-K2 |
Effects of liquiritigenin and iso-liquiritigenin, which are isolated from Glycyrrhiza, on a menopausal depressive-like state in ovariectomized mice |
Yoshimura |
Hiroyuki |
P1-K3 |
Psychopharmacological identifi cation of a new antidepressant-like component, (E)-9,10-dihydroxy-2-decenoic acid, from Honeybee royal jelly |
Sugimoto |
Yumi |
P1-K4 |
Involvement of the sigma receptor in in anti-immobility effects of fl uvoxamine in mice |
Rahmadi |
Mahardian |
P1-K5 |
Studies on drug dependence (Rept. 443): Research for the molecular mechanisms underlying sleep disturbance induced by chronic treatment wit SSRI and SNRI |
Miller |
David |
P1-O4 |
Improving Data Quality Throughout the Course of Global Alzheimer's Trials |
KONISHI |
SHIHO |
P1-RI3 |
Responsiveness of Ifrd1 as a differentiation regulator in neural progenitors to brain ischemia |
SHIBA |
TATSUO |
P1-RI6 |
Regulation by ryanodine receptors of proliferative activity in neural stem/ progenitor cells derived from subventricular zone of adult mice |
Oshimo |
Takashi |
P2-AII3 |
The effectiveness and safety of blonanserin in drugnaive patients with schizophrenia: An open label trial |
Kato |
Masaki |
P2-AIII1 |
Lurasidone in the Treatment of Acute Schizophrenia: Results of the Double- Blind, Placebo-Controlled PEARL 2 Trial |
Takekita |
Yoshiteru |
P2-AIII2 |
Effi cacy and Safety of Lurasidone in Schizophrenia: Results of a Phase 2, Placebo-Controlled, Study |
Morita |
Michiaki |
P2-AV4 |
Silent extrapyramidal syndrome induced by aripiprazole |
Nakano |
Wakako |
P2-AIX2 |
Reductions of polypharamacies of antipsychotic drugs with high dose in Japan; results from the REAP-3 study |
Tadori |
Yoshihiro |
P2-D1 |
Action of aripiprazole, its metabolite and experimental dopamine partial agonists at human dopamine D2 and D3 receptors |
Umezu |
Toyoshi |
P2-G6 |
Behavioral pharmacology of plant-derived substances (23): Effects of essential oils on ambulation in mice. Comparison with their effects on Shuttle type conditioned avoidance response |
Nakayama |
Yukari |
P2-G7 |
Behavioral changes and neural regeneration after hippocampal dentate injury in mice |
Iga |
Junichi |
P2-L1 |
Lithium decreases VEGF mRNA expression in leukocytes of healthy subjects and bipolar patients |
Ikenouchi-Sugita |
Atsuko |
P2-N1 |
No association between polymorphisms of Brain-derived neurotrophic factor (BDNF) Val66Met and psychiatric symptoms in systemic lupus erythematosus |
Nishimura |
Katsuji |
P2-N2 |
Risperidone in the treatment of corticosteroid-induced mood disorders in systemic lupus erythematosus: a case series |
Kuroiwa |
Mahomi |
P2-RII1 |
Role of phosphodiesterase 4 in dopamine D1 receptor/cAMP/PKA signaling in the frontal cortex |
Sako |
Aya |
P2-RII6 |
Translocation of glutamine transporter expressed in C6 glioma cells |
Nishizawa |
Daisuke |
P2-RII7 |
Association between GIRK3 gene polymorphisms and postoperative analgesic requirements after major abdominal surgery |